Page last updated: 2024-10-15

fructooligosaccharide

Cross-References

ID SourceID
PubMed CID138392202
CHEBI ID190523
MeSH IDM0299655

Synonyms (6)

Synonym
CHEBI:190523
fructooligosaccharide
fructo-oligosaccharide dp12/gf11
AKOS037515376
HY-N7009
CS-0101572

Research Excerpts

Overview

Fructooligosaccharides (FOS) are a well-known class of prebiotic. They are considered to selectively stimulate the growth of bifidobacteria in the gut. FOS can enhance immunological responses in the host.

ExcerptReference
"Fructooligosaccharides (FOS) are a kind of prebiotic. "( Effects of fructooligosaccharides (FOS) on the composition of cecal and fecal microbiota and the quantitative detection of FOS-metabolizing bacteria using species-specific primers.
Chen, W; Cui, S; Gu, J; Liu, Z; Mao, B; Tang, X; Zhang, H; Zhao, J, 2022
)
"Fructooligosaccharide (FOS) is a fermentable prebiotic that stimulates the growth of bifidobacteria and may promote anti-inflammatory activity."( Prebiotic Supplementation Following Ileocecal Resection in a Murine Model is Associated With a Loss of Microbial Diversity and Increased Inflammation.
Dicken, B; Fedorak, RN; Hotte, N; Laffin, M; Madsen, KL; Park, H; Perry, T; Thiesen, A, 2017
)
"Fructooligosaccharides (FOS) are a well-known class of prebiotic and are considered to selectively stimulate the growth of bifidobacteria in the gut. "( Effects of Different Doses of Fructooligosaccharides (FOS) on the Composition of Mice Fecal Microbiota, Especially the Bifidobacterium Composition.
Chen, W; Cui, S; Gu, J; Li, D; Mao, B; Zhang, H; Zhao, J, 2018
)
"Fructooligosaccharides (FOS) are a prebiotic supplement, which can enhance immunological responses in the host to activate mucosal immunity probably through regulation of gastrointestinal microflora. "( Dietary supplementation with fructooligosaccharides attenuates allergic peritonitis in mice.
Ichinose, T; Inoue, K; Sanbongi, C; Takano, H; Tanaka, M; Yanagisawa, R; Yasuda, A; Yoshikawa, T, 2012
)

Effects

Fructooligosaccharides (FOS) have been identified as important prebiotics. FOS has been reported to increase Lactobacillus and Bifidobacterium populations in animal and human gut.

ExcerptReference
"Fructooligosaccharides (FOS) have been identified as important prebiotics. "( Bifidobacteria exhibited stronger ability to utilize fructooligosaccharides, compared with other bacteria in the mouse intestine.
Cui, S; Gu, J; Liu, Z; Mao, B; Tang, X; Zhang, H; Zhao, J, 2022
)
"Fructooligosaccharide (FOS) has been reported to increase Lactobacillus and Bifidobacterium populations in animal and human gut. "( Continuously Ingesting Fructooligosaccharide Can't Maintain Rats' Gut Bifidobacterium at a High Level.
Chen, L; Gao, L; Li, S; Ou, S; Peng, X; Y, W, 2015
)
"Fructooligosaccharides (FOS) have been shown to stimulate the absorption of several minerals in the intestine. "( Dietary fructooligosaccharides prevent a reduction of cortical and trabecular bone following total gastrectomy in rats.
Morohashi, T; Ohta, A; Yamada, S, 2000
)

Actions

ExcerptReference
"Fructooligosaccharides (FOS) increase the growth of lactic acid bacteria (LAB) and promote butyrate and lactate production. "( The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats.
Cherbut, C; Lecannu, G; Michel, C, 2003
)

Toxicity

ExcerptReference
" Oral administration up to 5000 mg/kg bw/day to rats over 90 days was not associated with any adverse effects, based on clinical observations, body weight gain, feed consumption, clinical pathology, organ weights and histopathology findings."( Pre-clinical safety assessment of the synthetic human milk, nature-identical, oligosaccharide Lacto-N-neotetraose (LNnT).
Constable, A; Coulet, M; Marsden, E; Phothirath, P; Schilter, B, 2013
)
" There were no compound-related adverse effects in the 90-day study; therefore, 4000 mg/kg bw/day (the highest feasible dose) was established as the no-observed-adverse-effect-level."( Preclinical safety evaluation of the human-identical milk oligosaccharide lacto-N-tetraose.
Baldwin, N; Gilby, B; Lynch, B; Mikš, MH; Phipps, KR; Röhrig, CH; Šoltesová, A; Stannard, DR, 2018
)
" No clinically relevant differences in adverse events were observed, apart from a lower investigator-reported prevalence of infantile colic in the experimental versus control group (1."( Gastrointestinal Tolerance, Growth and Safety of a Partly Fermented Formula with Specific Prebiotics in Healthy Infants: A Double-Blind, Randomized, Controlled Trial.
Abrahamse-Berkeveld, M; Agosti, M; Bouritius, H; Corvaglia, L; Lista, G; Ludwig, T; Mulder, K; Muñoz, A; Perez-Navero, JL; Rodriguez-Herrera, A; Rubio, R, 2019
)
" No mortalities or significant adverse effects were recorded in non-infected treated-groups while infected were (20%) LEV, (30%) CNPs, (40%) FOS and (70%) G2."( Assessment the efficacy of some various treatment methods, in vitro and in vivo, against Aeromonas hydrophila infection in fish with regard to side effects and residues.
El-Sherbeny, EME; Kassem, S; Khoris, EA, 2022
)

Compound-Compound Interactions

ExcerptReference
" This paper focuses on the enhancement of the efficacy of probiotics by their combination with synergistically acting components of natural origin."( Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids.
Bomba, A; Gancarcíková, S; Guba, P; Herich, R; Mudronová, D; Nemcová, R, 2002
)
"05) were observed among hens fed alfalfa combined with FOS and hens fed alfalfa/layer ration without FOS."( The influence of a fructooligosaccharide prebiotic combined with alfalfa molt diets on the gastrointestinal tract fermentation, Salmonella enteritidis infection, and intestinal shedding in laying hens.
Chalova, VI; Donalson, LM; Kim, WK; Kubena, LF; McReynolds, JL; Nisbet, DJ; Ricke, SC; Woodward, CL, 2008
)

Bioavailability

igosaccharides (FOS) may exhibit a cooperative bone-sparing effect. FOS are known to modify large-bowel flora and metabolism.

ExcerptReference
"The influence of dietary fructooligosaccharides (FOS) on bioavailability of genistein and daidzein in rats was estimated by measuring their concentrations in plasma collected from three different veins and in urine after a single intragastric administration of isoflavone conjugates."( Dietary fructooligosaccharides modify intestinal bioavailability of a single dose of genistein and daidzein and affect their urinary excretion and kinetics in blood of rats.
Adlercreutz, H; Ohta, A; Sakai, K; Suzuki, K; Uehara, M; Watanabe, S, 2001
)
" These results suggest that FOS increase the bioavailability of isoflavones, leading to cooperative effects in the prevention of osteopenia in OVX mice."( A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice.
Adlercreutz, H; Ishimi, Y; Morohashi, T; Ohta, A; Sakai, K; Takasaki, M; Uehara, M, 2002
)
" As their bioavailability could be improved by modulating intestinal microflora, the present study was undertaken to investigate whether IF and fructooligosaccharides (FOS), which are known to modify large-bowel flora and metabolism, may exhibit a cooperative bone-sparing effect."( Fructooligosaccharides maximize bone-sparing effects of soy isoflavone-enriched diet in the ovariectomized rat.
Bennetau-Pelissero, C; Coxam, V; Davicco, MJ; Horcajada, MN; Kati-Coulibaly, S; Lebecque, P; Mathey, J; Puel, C, 2004
)
" Furthermore dietary sc-FOS influences on bioavailability of soy-isoflavones."( Novel physiological function of fructooligosaccharides.
Tokunaga, T, 2004
)
" However, when flux data were based on the total caecal surface area, INOF-fed rats nearly doubled absorption rate in caecum."( Mechanisms underlying the effects of inulin-type fructans on calcium absorption in the large intestine of rats.
Daniel, H; Raschka, L, 2005
)
"The bioavailability of cellobiose (CEB) was investigated with respect to small intestinal digestibility and cecal fermentation in rats."( Cellobiose is extensively digested in the small intestine by beta-galactosidase in rats.
Ito, H; Kimio, S; Kiriyama, S; Morita, T; Ozawa, M,
)
" It was concluded that suppression of degrading quercetin aglycone in the large intestine has a major role for increasing alpha G-rutin bioavailability by DFA III and FOS feedings."( Oligosaccharide promotes bioavailability of a water-soluble flavonoid glycoside, alpha G-rutin, in rats.
Chiji, H; Hara, H; Matsukawa, N; Matsumoto, M, 2009
)
"The present study investigated the effects of fructo-oligosaccharides (FOS) on the bioavailability of Fe from ferric pyrophosphate (FP), a water-insoluble compound, in Fe-deficient anaemic rats that were subjected to a Hb repletion assay."( Fructo-oligosaccharides and iron bioavailability in anaemic rats: the effects on iron species distribution, ferroportin-1 expression, crypt bifurcation and crypt cell proliferation in the caecum.
Alvares, EP; Colli, C; De Carli, E; Gaievski, EH; Lobo, AR, 2014
)
" Bioavailability and metabolism of these red clover isoflavones (RCI) have not been studied in detail."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
"To determine the bioavailability of RCI metabolites and analyse whether FOS supplementation could influence their bioavailability."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
" In the first, compound bioavailability was determined after consumption of 80 mg of RCI (MF11RCE)."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
" Supplementation with FOS led to a significant decrease in the bioavailability of daidzein, dihydroformononetin, dihydrogenistein and dihydrodaidzein."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
"This study is the first to provide detailed data on RCI bioavailability in humans and determine no influence of FOS yet a trend toward increased equol production."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
" The bioavailability of RG and HRG was investigated by in vitro experiments using human and rat small intestinal enzymes and by in vivo experiments using rats in the present study."( Digestibility of new dietary fibre materials, resistant glucan and hydrogenated resistant glucan in rats and humans, and the physical effects in rats.
Hamaguchi, N; Morita, S; Nakamura, S; Oku, T; Shimura, F; Tanabe, K, 2015
)
" Experimental calcium-fortified gluten-free bread (GFB) of improved calcium bioavailability could increase calcium content in the diets of coeliac disease patients, allowing them to obtain the amount of calcium they need for therapeutic use."( Inulin and fructooligosaccharide affect in vitro calcium uptake and absorption from calcium-enriched gluten-free bread.
Bączek, N; Brzóska, MM; Krupa-Kozak, U; Swiątecka, D, 2016
)
" The aim of our study was to evaluate iron bioavailability of YCF relative to prebiotic and AA concentrations."( In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics.
Christides, T; Ganis, JC; Sharp, PA, 2018
)
"We used the in vitro digestion/Caco-2 cell model to measure iron bioavailability from 4 commercially available YCF with approximately equal amounts of iron, but varying amounts of: AA and the prebiotics fructo- and galacto-oligosaccharides."( In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics.
Christides, T; Ganis, JC; Sharp, PA, 2018
)

Dosage Studied

ExcerptReference
"These data indicate that supplementation of a term infant's formula with a mixture of galacto- and fructooligosaccharides has a dose-dependent stimulating effect on the growth of Bifidobacteria and Lactobacilli in the intestine and results in softer stool with increasing dosage of supplementation."( Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants.
Boehm, G; Fanaro, S; Jelinek, J; Minoli, I; Moro, G; Mosca, M; Stahl, B, 2002
)
" At each feeding, dogs were dosed with either 1 g sucrose (placebo) or 2 g FOS plus 1 g MOS orally via gelatin capsule."( Effects of supplemental fructooligosaccharides plus mannanoligosaccharides on immune function and ileal and fecal microbial populations in adult dogs.
Dawson, KA; Fahey, GC; Flickinger, EA; Grieshop, CM; Healy, HP; Merchen, NR; Swanson, KS, 2002
)
"5 to 10 g/d, and that there is a dose-response relationship in healthy volunteers."( The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans.
Bornet, F; Bouhnik, Y; Paineau, D; Raskine, L; Simoneau, G, 2006
)
" No significant relationship was found between the dosage of FOS or soy isoflavones and the concentration of fecal secondary bile acid."( Fructooligosaccharide and soy isoflavone suppress colonic aberrant crypt foci and cyclooxygenase-2 expression in dimethylhydrazine-treated rats.
Choi, YS; Sung, HY, 2008
)
" The subjects consumed six different mixtures of dextrose, maltitol and scFOS added in a chocolate dairy dessert at a dosage of 35 g."( Digestive tolerance and postprandial glycaemic and insulinaemic responses after consumption of dairy desserts containing maltitol and fructo-oligosaccharides in adults.
Cazaubiel, M; Chauveau, P; Gendre, D; Hilpipre, C; Maudet, C; Respondek, F; Wagner, A, 2014
)
" In addition, FO attenuated the d-galactose-induced protein expression of Aβ and beta-site amyloid precursor cleaving enzyme of the whole brain in a dose-response manner."( Fructo-oligosaccharide improved brain β-amyloid, β-secretase, cognitive function, and plasma antioxidant levels in D-galactose-treated Balb/cJ mice.
Chen, HL; Wang, CH; Wu, WT; Yen, CH, 2017
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
oligosaccharideA compound in which monosaccharide units are joined by glycosidic linkages. The term is commonly used to refer to a defined structure as opposed to a polymer of unspecified length or a homologous mixture. When the linkages are of other types the compounds are regarded as oligosaccharide analogues.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (649)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (0.77)18.2507
2000's188 (28.97)29.6817
2010's326 (50.23)24.3611
2020's130 (20.03)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials92 (13.61%)5.53%
Reviews41 (6.07%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other543 (80.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]